January 4, 2018

Study shows virus-boosted immunotherapy can be effective against aggressive breast cancer

The Maraba virus is seen under an electron microscope

Researchers at The Ottawa Hospital and the University of Ottawa have found that a combination of two immunotherapies – oncolytic viruses and checkpoint inhibitors – was successful in treating triple-negative breast cancer in mouse models. Triple-negative breast cancer is the most aggressive and hard-to-treat form of the disease.

Continue reading – Study shows virus-boosted immunotherapy can be effective against aggressive breast cancer